Laure Saint-Aubert

Toulouse 3 
"Laure Saint-Aubert"
Mean distance: (not calculated yet)


Sign in to add mentor
Michele Fabre-Thorpe grad student 2012 Toulouse 3
 (Étude multimodale de la maladie d'Alzheimer : forme sporadique prodromale, formes génétiques, et altération du traitement visuel)


Sign in to add trainee
Konstantinos Chiotis grad student 2013-2017 Karolinska
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Chiotis K, Savitcheva I, Poulakis K, et al. (2020) [F]THK5317 imaging as a tool for predicting prospective cognitive decline in Alzheimer's disease. Molecular Psychiatry
Lemoine L, Gillberg PG, Bogdanovic N, et al. (2020) Amyloid, tau, and astrocyte pathology in autosomal-dominant Alzheimer's disease variants: AβPParc and PSEN1DE9. Molecular Psychiatry
Leuzy A, Cicognola C, Chiotis K, et al. (2019) Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging
Thordardottir S, Rodriguez-Vieitez E, Almkvist O, et al. (2018) Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study. Alzheimer's Research & Therapy. 10: 45
Leuzy A, Rodriguez-Vieitez E, Saint-Aubert L, et al. (2017) Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Frisoni GB, Boccardi M, Barkhof F, et al. (2017) Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers. The Lancet. Neurology. 16: 661-676
Lemoine L, Saint-Aubert L, Nennesmo I, et al. (2017) Cortical laminar tau deposits and activated astrocytes in Alzheimer's disease visualised by (3)H-THK5117 and (3)H-deprenyl autoradiography. Scientific Reports. 7: 45496
Chiotis K, Saint-Aubert L, Boccardi M, et al. (2017) Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework. Neurobiology of Aging. 52: 214-227
Saint-Aubert L, Lemoine L, Chiotis K, et al. (2017) Tau PET imaging: present and future directions. Molecular Neurodegeneration. 12: 19
Saint-Aubert L, Almkvist O, Chiotis K, et al. (2016) Regional tau deposition measured by [(18)F]THK5317 positron emission tomography is associated to cognition via glucose metabolism in Alzheimer's disease. Alzheimer's Research & Therapy. 8: 38
See more...